Kyverna Therapeutics, Inc. (KYTX) Operating cash flow 2023–2025
Kyverna Therapeutics, Inc. (KYTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$153.7MFY2025 · since FY2023: -$52.4M → -$153.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$153.7M | -34.5% |
| FY2024 | -$114.3M | -118.0% |
| FY2023 | -$52.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice